anmelden
LeMaitre Vascular Aktie
81,50
EUR
-0,50
EUR
-0,61
%
93,91
USD
+1,70
USD
+1,84
%
LeMaitre Vascular jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
LeMaitre Vascular Aktie Analyse
| 25.07.19 | LeMaitre Vascular Outperform | Barrington Research | |
| 25.07.19 | LeMaitre Vascular Outperform | First Analysis Securities | |
| 08.10.18 | LeMaitre Vascular Outperform | Barrington Research | |
| 26.04.18 | LeMaitre Vascular Buy | The Benchmark Company | |
| 26.04.18 | LeMaitre Vascular Hold | Stifel, Nicolaus & Co., Inc. | |
| 21.03.17 | LeMaitre Vascular Overweight | First Analysis Securities | |
| 25.02.16 | LeMaitre Vascular Outperform | Barrington Research | |
| 07.12.15 | LeMaitre Vascular Buy | Dougherty & Company LLC | |
|
Werbung
|
|||
| 07.12.15 | LeMaitre Vascular Buy | ROTH Capital Partners, LLC | |
| 04.12.15 | LeMaitre Vascular Buy | Stifel, Nicolaus & Co., Inc. | |
| 28.10.15 | LeMaitre Vascular Outperform | Barrington Research | |
| 29.07.15 | LeMaitre Vascular Buy | The Benchmark Company | |
| 29.07.15 | LeMaitre Vascular Buy | Brean Capital | |
| 29.07.15 | LeMaitre Vascular Buy | ROTH Capital Partners, LLC | |
| 19.06.15 | LeMaitre Vascular Buy | Dougherty & Company LLC | |
Werbung
Werbung